SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-049397
Filing Date
2021-02-22
Accepted
2021-02-19 21:41:01
Documents
13
Period of Report
2021-02-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d64377d8k.htm   iXBRL 8-K 38606
2 EX-2.1 d64377dex21.htm EX-2.1 143263
  Complete submission text file 0001193125-21-049397.txt   333719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210219.xsd EX-101.SCH 2719
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210219_lab.xml EX-101.LAB 18064
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210219_pre.xml EX-101.PRE 11362
6 EXTRACTED XBRL INSTANCE DOCUMENT d64377d8k_htm.xml XML 3448
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 21658088
SIC: 2833 Medicinal Chemicals & Botanical Products